● Recruiting

Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients

Condition: Myocardial Infarction · Sponsor: Novartis Pharmaceuticals

PhaseN/A

Planned participants300

Who can joinAll sexes, 18 Years to 100 Years

Healthy volunteersNo

About this study

Evaluation of clinical outcomes during 12 months after inclisiran initiation in patients after STEMI/non-STEMI in real-world settings in Russia. It is also planned to study the therapy effect on the lipid profile characteristics, its safety, the state of atherosclerotic plaques according to carotid ultrasound, the frequency of hospitalizations and the need for intensive follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · +41613241111 · novartis.email@novartis.com

Novartis Pharmaceuticals

Always discuss trial participation with your own doctor first.

Locations (16)

Novartis Investigative Site	Cheboksary, Russia	Recruiting
Novartis Investigative Site	Grozny, Russia	Recruiting
Novartis Investigative Site	Kemerovo, Russia	Recruiting
Novartis Investigative Site	Khanty-Mansiysk, Russia	Recruiting
Novartis Investigative Site	Moscow, Russia	Recruiting
Novartis Investigative Site	Moscow, Russia	Recruiting
Novartis Investigative Site	Moscow, Russia	Recruiting
Novartis Investigative Site	Novosibirsk, Russia	Recruiting
Novartis Investigative Site	Penza, Russia	Recruiting
Novartis Investigative Site	Petrozavodsk, Russia	Recruiting
Novartis Investigative Site	Rostov-on-Don, Russia	Recruiting
Novartis Investigative Site	S Petersburg, Russia	Recruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07142265